Ji John S

Ying Pan (yingpan@stanford.edu) is a senior scientist at the Stanford University School of Medicine, where she had her postdoctoral fellowship. She received her Ph.D. degree in virology from Wuhan University, China, and her bachelor's degree in biochemical engineering from Hubei University, China. She is interested in molecular diagnostics for cancer and infectious disease. John S. Ji (johnji@post.harvard.edu) is a senior researcher at Harvard Business School and an adjunct research fellow at Peking University School of Public Health, Beijing, China. Previously, he worked for the China Medical Board and the U.S. Food and Drug Administration. He received his bachelor's degree from Johns Hopkins University and doctor of science degree from Harvard School of Public Health. Jason (Gang) Jin (jason.jin@cloudhealth99.com) is a member of the National Thousand Talents Program in China; founder and chief executive officer (CEO) of Cloud-Health Genomics, Ltd., and CloudHealth Medical Group, Ltd.; chair and CEO of ShanghaiBio Corporation; cofounder and founding director of the National Engineering Center for Biochip at Shanghai (Shanghai Biochip Co. Ltd); and cofounder and founding CEO of Shanghai Biotechnology Corporation. Dr. Jin is also an adjunct professor at the Shanghai Institutes of Biological Sciences, the Chinese Academy of Sciences, Fudan University, and Shanghai Jiaotong University. He received his Ph.D. and postdoctoral fellow degrees in biology from the University of California, San Diego. He graduated from the School of Medicine, Fudan University (Shanghai Medical University, China). Dr. Jin also attended the intensive MBA program at Rutgers, the State University of New Jersey, United States. Winston Patrick Kuo (winston.kuo@cloudhealth99.com) is the chief technology officer and head of business development with CloudHealth Genomics, Ltd., Shanghai, China. He was formerly president of Predicine Holdings Ltd., an international precision-medicine organization committed to developing innovative diagnostics, therapeutics, and big data in cancer and other serious diseases; he was chief operating officer with IES Diagnostics. Prior to industry, Dr. Kuo was an assistant professor in the Department of Developmental Biology at the Harvard School of Dental Medicine, and he was director and founder of the Harvard Clinical and Translational Science-Laboratory for Innovative Translational Technologies at the Harvard Medical School to provide the university's biomedical research community with early access to disruptive and enabling leading-edge translational technologies. Hongjun Kang (doctorklbd@126.com) is a senior physician and associated professor at the Chinese PLA General Hospital. He received his Ph.D. degree in surgery from the Chinese PLA medical school, Beijing, China, and a bachelor's degree in clinical medicine from Chengde Medical School, China. He is interested in biomarkers diagnostics for sepsis and infectious disease.